Identifying Prostate Brachytherapy Seeds Using MRI

University Health Network, Toronto

Status: Completed

Conditions: Prostate Cancer Patients Who Have Brachytherapy Seed Implant

Treatments: Other: MRI Scan

Study type: Interventional

Funder types: Other

Identifiers

NCT01878058

UHN REB 12-5302-CE

Details and patient eligibility

About

This study will look at the feasibility of using a type of Magnetic Resonance Imaging called Susceptibility Weighted Imaging (SWI) to detect your implanted radioactive seeds. Researchers hope that using SWI will eliminate the need to use CT imaging to detect your implanted radioactive seeds.

This study will also see if the MRI seed detection is as effective as current standard practice of seed detection (routine MRI and CT imaging). This technique would be beneficial for brachytherapy without the need to fuse the MRI and CT images, as is done currently.

Enrollment: 10 estimated patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. At least 18 years old
2. Histologic diagnosis of adenocarcinoma of the prostate
3. No contraindications for Pelvic body MRI
4. Patients undergoing LDR brachytherapy at PMH and scheduled for post implant analysis with CT-MR (standard at PMH)
5. Ability to provide written informed consent to participate in the study

Exclusion criteria

1. Contraindication for Pelvic body MRI
2. Patient not willing/consenting for this study

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

MRI Scan

Other group

Description:

Patients will receive an extra MRI scan in addition to their routine scan.

Treatment:

Other: MRI Scan